Search Results 641-650 of 23347 for mindfullness research
Julie Ann Vera, M.S.. January 28, 2025. Mayo Clinic opens new doors in cancer treatment innovation featured image. Individualized Medicine.
The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by ...
The purpose of this study is to assess the feasibility of enrolling, randomizing treatment strategies and retaining participants with frequent premature ...
The objective of the study is to gather information to assist healthcare providers and future patients in understanding long-haul COVID-19 and its ...
The purpose of this study is to measure overall activity (sedentary-to-high intensity) during rehab and at 1 year follow-up. Participation eligibility.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
In adults with normal cognition or mild cognitive impairment, Ginkgo biloba does not slow cognitive decline. Although some studies have shown slight ...
About this study. The purpose of this study is to: To assess the health knowledge, behaviors, and health outcomes of program participants.
The purpose of this study is to probe into reasons why patients and healthcare providers might not discuss sexual orientation and gender identity as well as ...
About this study. The primary purpose of this research study is to collect a large enough sample of fat cells (preadipocytes) and blood from patients ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!